| Altos Health | |
|
2242 Camden Ave Ste 204 San Jose CA 95124-2029 | |
| (650) 383-4768 | |
| (650) 772-5372 |
| Full Name | Altos Health |
|---|---|
| Speciality | Internal Medicine |
| Location | 2242 Camden Ave Ste 204, San Jose, California |
| Authorized Official Name and Position | Inna Yaskin (PHYSICIAN) |
| Authorized Official Contact | 7326917599 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Altos Health 2242 Camden Ave Ste 204 San Jose CA 95124-2029 Ph: (650) 383-4768 | Altos Health 2242 Camden Ave Ste 204 San Jose CA 95124-2029 Ph: (650) 383-4768 |
| NPI Number | 1023748811 |
|---|---|
| Provider Enumeration Date | 06/14/2022 |
| Last Update Date | 03/28/2023 |
| Medicare PECOS PAC ID | 3779965207 |
|---|---|
| Medicare Enrollment ID | O20220801001070 |
News Archive
A novel single-pill combination drug could present a new treatment option for patients with the most difficult-to-treat forms of hepatitis C, according to the results of a Phase 2 trial, published in The Lancet.
Childhood cancer survivors typically suffer from the long-term effects of cancer treatment on physical health, and results of a new study suggest that social implications also exist, which may affect their chance of an "I do" at the altar.
Biomedical engineers at Duke University have shown that different strains of the same bacterial pathogen can be distinguished by a machine learning analysis of their growth dynamics alone, which can then also accurately predict other traits such as resistance to antibiotics.
Boston Scientific Corporation today announced the U.S. and European launches of the Neuroform EZ™ Stent System, its fourth-generation intracranial aneurysm stent system designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms. The Company plans to launch the product immediately in both markets.
A clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa. The drug, moxidectin, is being investigated for its potential to kill or sterilize the adult worms of Onchocerca volvulus, which cause onchocerciasis.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023748811 | NPI | - | NPPES |
| CA552297 | Other | CA | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Patricia Roukee Sitnitsky |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1790896231 PECOS PAC ID: 3971547829 Enrollment ID: I20050613000617 |
News Archive
A novel single-pill combination drug could present a new treatment option for patients with the most difficult-to-treat forms of hepatitis C, according to the results of a Phase 2 trial, published in The Lancet.
Childhood cancer survivors typically suffer from the long-term effects of cancer treatment on physical health, and results of a new study suggest that social implications also exist, which may affect their chance of an "I do" at the altar.
Biomedical engineers at Duke University have shown that different strains of the same bacterial pathogen can be distinguished by a machine learning analysis of their growth dynamics alone, which can then also accurately predict other traits such as resistance to antibiotics.
Boston Scientific Corporation today announced the U.S. and European launches of the Neuroform EZ™ Stent System, its fourth-generation intracranial aneurysm stent system designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms. The Company plans to launch the product immediately in both markets.
A clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa. The drug, moxidectin, is being investigated for its potential to kill or sterilize the adult worms of Onchocerca volvulus, which cause onchocerciasis.
› Verified 4 days ago
| Provider Name | Inna Yaskin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1316965353 PECOS PAC ID: 7810940707 Enrollment ID: I20110301001103 |
News Archive
A novel single-pill combination drug could present a new treatment option for patients with the most difficult-to-treat forms of hepatitis C, according to the results of a Phase 2 trial, published in The Lancet.
Childhood cancer survivors typically suffer from the long-term effects of cancer treatment on physical health, and results of a new study suggest that social implications also exist, which may affect their chance of an "I do" at the altar.
Biomedical engineers at Duke University have shown that different strains of the same bacterial pathogen can be distinguished by a machine learning analysis of their growth dynamics alone, which can then also accurately predict other traits such as resistance to antibiotics.
Boston Scientific Corporation today announced the U.S. and European launches of the Neuroform EZ™ Stent System, its fourth-generation intracranial aneurysm stent system designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms. The Company plans to launch the product immediately in both markets.
A clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa. The drug, moxidectin, is being investigated for its potential to kill or sterilize the adult worms of Onchocerca volvulus, which cause onchocerciasis.
› Verified 4 days ago
News Archive
A novel single-pill combination drug could present a new treatment option for patients with the most difficult-to-treat forms of hepatitis C, according to the results of a Phase 2 trial, published in The Lancet.
Childhood cancer survivors typically suffer from the long-term effects of cancer treatment on physical health, and results of a new study suggest that social implications also exist, which may affect their chance of an "I do" at the altar.
Biomedical engineers at Duke University have shown that different strains of the same bacterial pathogen can be distinguished by a machine learning analysis of their growth dynamics alone, which can then also accurately predict other traits such as resistance to antibiotics.
Boston Scientific Corporation today announced the U.S. and European launches of the Neuroform EZ™ Stent System, its fourth-generation intracranial aneurysm stent system designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms. The Company plans to launch the product immediately in both markets.
A clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa. The drug, moxidectin, is being investigated for its potential to kill or sterilize the adult worms of Onchocerca volvulus, which cause onchocerciasis.
› Verified 4 days ago
Chris Chung, Md, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 455 Oconnor Dr, #150, San Jose, CA 95128 Phone: 408-293-7767 Fax: 408-294-6595 | |
Tuan Le, M.d. A Professional Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1569 Lexann Ave, Suite 122, San Jose, CA 95121 Phone: 408-531-1555 | |
Frank D. Shin, Md, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1440 S De Anza Blvd, Suite A, San Jose, CA 95129 Phone: 408-366-0405 | |
Verity Medical Foundation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 227 N Jackson Ave, San Jose, CA 95116 Phone: 408-278-3000 | |
Leena Gupta Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4945 Bridgeview Ln, San Jose, CA 95138 Phone: 408-666-0392 | |
Shen Medicine & Pediatrics Assc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 316 Rosewood Ave, San Jose, CA 95117 Phone: 408-296-9800 Fax: 408-296-9805 | |
Terry C. Lin D.o.,inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2520 Samaritan Dr., #201, San Jose, CA 95124 Phone: 888-582-0814 |